Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty

Background: On an initial urine screening test for illegal substances, if the concentration of a substance is at or above the determined legislative threshold, it is reported as positive. Repeating testing with the same sample to verify it before reporting is a common practice in clinical laboratori...

Full description

Bibliographic Details
Main Authors: Huysal Kagan, Üstündağ Yasemin, Çağlak Hatice Azra, Rümeysa Yeşil Meryem
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2023-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582304616H.pdf
_version_ 1797396410249773056
author Huysal Kagan
Üstündağ Yasemin
Çağlak Hatice Azra
Rümeysa Yeşil Meryem
author_facet Huysal Kagan
Üstündağ Yasemin
Çağlak Hatice Azra
Rümeysa Yeşil Meryem
author_sort Huysal Kagan
collection DOAJ
description Background: On an initial urine screening test for illegal substances, if the concentration of a substance is at or above the determined legislative threshold, it is reported as positive. Repeating testing with the same sample to verify it before reporting is a common practice in clinical laboratories. This study aimed to determine whether measurement uncertainty (MU) results can be used to detect a grey zone to reduce repeat testing. Methods: A retrospective study was conducted using data from the laboratory information system between January 1, 2020, and July 1, 2022. Samples studied twice within one hour before reporting for the same urine sample were analyzed. The MU values for urinary amphetamine, cannabinoid, cocaine, and opioid parameters were calculated using ADVIA Chemistry reagents on a Siemens ADVIA 1800 chemical analyzer. The grey zone was defined as the cut-off value ± MU. Results: Urine samples, 319 amphetamine, 198 cannabinoid, 112 cocaine, and 125 opiate tests were repeated from 31.839 patients (16-65 years). Ten amphetamine, 12 can - nabinoid and 2 cocaine test results changed from positive to negative or negative to positive on retesting, all within the grey zone level defined by the MU value. Mean biases bet - ween the repeated test results were -7.64 (95% CI: -13.71 to -1.57) ng/mL for the amphetamine and 1.16 (95% CI: 0.31 to 2.01) ng/mL for the cannabinoid results. Conclusion: Repeating only values within the grey area for each illicit substance may be useful to reduce unnecessary duplicate measurements.
first_indexed 2024-03-09T00:50:52Z
format Article
id doaj.art-c5225dc4d3ff43f8a55b9ac42b657e0a
institution Directory Open Access Journal
issn 1452-8258
1452-8266
language English
last_indexed 2024-03-09T00:50:52Z
publishDate 2023-01-01
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format Article
series Journal of Medical Biochemistry
spelling doaj.art-c5225dc4d3ff43f8a55b9ac42b657e0a2023-12-11T17:15:36ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662023-01-0142461662010.5937/jomb0-417771452-82582304616HReducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertaintyHuysal Kagan0Üstündağ Yasemin1Çağlak Hatice Azra2Rümeysa Yeşil Meryem3University of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Department of Clinical Biochemistry, Bursa, TurkeyUniversity of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Department of Clinical Biochemistry, Bursa, TurkeyUniversity of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Department of Clinical Biochemistry, Bursa, TurkeyUniversity of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Department of Clinical Biochemistry, Bursa, TurkeyBackground: On an initial urine screening test for illegal substances, if the concentration of a substance is at or above the determined legislative threshold, it is reported as positive. Repeating testing with the same sample to verify it before reporting is a common practice in clinical laboratories. This study aimed to determine whether measurement uncertainty (MU) results can be used to detect a grey zone to reduce repeat testing. Methods: A retrospective study was conducted using data from the laboratory information system between January 1, 2020, and July 1, 2022. Samples studied twice within one hour before reporting for the same urine sample were analyzed. The MU values for urinary amphetamine, cannabinoid, cocaine, and opioid parameters were calculated using ADVIA Chemistry reagents on a Siemens ADVIA 1800 chemical analyzer. The grey zone was defined as the cut-off value ± MU. Results: Urine samples, 319 amphetamine, 198 cannabinoid, 112 cocaine, and 125 opiate tests were repeated from 31.839 patients (16-65 years). Ten amphetamine, 12 can - nabinoid and 2 cocaine test results changed from positive to negative or negative to positive on retesting, all within the grey zone level defined by the MU value. Mean biases bet - ween the repeated test results were -7.64 (95% CI: -13.71 to -1.57) ng/mL for the amphetamine and 1.16 (95% CI: 0.31 to 2.01) ng/mL for the cannabinoid results. Conclusion: Repeating only values within the grey area for each illicit substance may be useful to reduce unnecessary duplicate measurements.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582304616H.pdfcut-offgrey zonemeasurement uncertaintyamphetaminecannabinoidcocaine
spellingShingle Huysal Kagan
Üstündağ Yasemin
Çağlak Hatice Azra
Rümeysa Yeşil Meryem
Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
Journal of Medical Biochemistry
cut-off
grey zone
measurement uncertainty
amphetamine
cannabinoid
cocaine
title Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
title_full Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
title_fullStr Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
title_full_unstemmed Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
title_short Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
title_sort reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty
topic cut-off
grey zone
measurement uncertainty
amphetamine
cannabinoid
cocaine
url https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2023/1452-82582304616H.pdf
work_keys_str_mv AT huysalkagan reducingtheneedforrepeatingurinedrugtestingwiththegrayzonedeterminedbythemeasurementuncertainty
AT ustundagyasemin reducingtheneedforrepeatingurinedrugtestingwiththegrayzonedeterminedbythemeasurementuncertainty
AT caglakhaticeazra reducingtheneedforrepeatingurinedrugtestingwiththegrayzonedeterminedbythemeasurementuncertainty
AT rumeysayesilmeryem reducingtheneedforrepeatingurinedrugtestingwiththegrayzonedeterminedbythemeasurementuncertainty